Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Busuttil

Showing results (461-470 of 831) with videos related to

Pageof 84
Sort By:
AJR. American Journal of Roentgenology|February 1, 1990
Color Doppler imaging of portosystemic shuntsE G Grant, F N Tessler, A S Gomes, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 22, 2007
Outcome of liver transplantation in septuagenarians: a single-center experienceGerald S Lipshutz, Jonathan Hiatt, R Mark Ghobrial, et al.
Human Gene Therapy|June 19, 2009
Small interfering RNA targeting heme oxygenase-1 (HO-1) reinforces liver apoptosis induced by ischemia-reperfusion injury in mice: HO-1 is necessary for cytoprotectionBibo Ke, Xiu-Da Shen, Feng Gao, et al.
Gastrointestinal Endoscopy|March 2, 2010
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video)James H Tabibian, Emad H Asham, Steven Han, et al.
Hepatology (Baltimore, Md.)|January 24, 2003
Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotectionXiu-Da Shen, Bibo Ke, Yuan Zhai, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 28, 2001
Outcome after intestinal transplantation: results from one center's 9-year experience; discussion 1031-2D G Farmer, S V McDiarmid, H Yersiz, et al.
AJR. American Journal of Roentgenology|November 26, 2009
Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patientsAntoinette S Gomes, Michael H Rosove, Peter J Rosen, et al.
Hepatology (Baltimore, Md.)|July 29, 2014
T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injuryHaofeng Ji, Yuanxing Liu, Yu Zhang, et al.
The American Surgeon|October 23, 2003
Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survivalMing-Sing Si, Farin Amersi, S Raymond Golish, et al.
Transplantation Proceedings|March 27, 2001
Heme oxygenase-1 gene therapy: a novel immunomodulatory approach in liver allograft recipients?B Ke, X D Shen, J Melinek, et al.
Pageof 84

Showing results (461-470 of 831) with videos related to

Sort By:
Pageof 84
AJR. American Journal of Roentgenology|February 1, 1990
Color Doppler imaging of portosystemic shuntsE G Grant, F N Tessler, A S Gomes, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 22, 2007
Outcome of liver transplantation in septuagenarians: a single-center experienceGerald S Lipshutz, Jonathan Hiatt, R Mark Ghobrial, et al.
Human Gene Therapy|June 19, 2009
Small interfering RNA targeting heme oxygenase-1 (HO-1) reinforces liver apoptosis induced by ischemia-reperfusion injury in mice: HO-1 is necessary for cytoprotectionBibo Ke, Xiu-Da Shen, Feng Gao, et al.
Gastrointestinal Endoscopy|March 2, 2010
Endoscopic treatment of postorthotopic liver transplantation anastomotic biliary strictures with maximal stent therapy (with video)James H Tabibian, Emad H Asham, Steven Han, et al.
Hepatology (Baltimore, Md.)|January 24, 2003
Stat4 and Stat6 signaling in hepatic ischemia/reperfusion injury in mice: HO-1 dependence of Stat4 disruption-mediated cytoprotectionXiu-Da Shen, Bibo Ke, Yuan Zhai, et al.
Archives of Surgery (Chicago, Ill. : 1960)|September 28, 2001
Outcome after intestinal transplantation: results from one center's 9-year experience; discussion 1031-2D G Farmer, S V McDiarmid, H Yersiz, et al.
AJR. American Journal of Roentgenology|November 26, 2009
Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patientsAntoinette S Gomes, Michael H Rosove, Peter J Rosen, et al.
Hepatology (Baltimore, Md.)|July 29, 2014
T-cell immunoglobulin and mucin domain 4 (TIM-4) signaling in innate immune-mediated liver ischemia-reperfusion injuryHaofeng Ji, Yuanxing Liu, Yu Zhang, et al.
The American Surgeon|October 23, 2003
Prevalence of metastases in hepatocellular carcinoma: risk factors and impact on survivalMing-Sing Si, Farin Amersi, S Raymond Golish, et al.
Transplantation Proceedings|March 27, 2001
Heme oxygenase-1 gene therapy: a novel immunomodulatory approach in liver allograft recipients?B Ke, X D Shen, J Melinek, et al.
Pageof 84